SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
Clin. transl. oncol. (Print)
; 24(4): 659-669, abril 2022.
Article
in English
| IBECS
| ID: ibc-203770
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
Esophageal cancer is an aggressive tumor, and is the sixth-leading cause of death from cancer. Incidence is rising in Spain, particularly among men. Two main pathological different subtypes have been described squamous cell carcinoma and adenocarcinoma. Growing evidence of their epidemiology and molecular differences explains their different response to novel treatments, and they are therefore likely to be treated as two separate entities in the near future. The best results are obtained with a multidisciplinary therapeutic strategy, and the introduction of immunotherapy is a promising new approach that will improve prognosis. In these guidelines, we review the evidence for the different methods of diagnosis and therapeutic strategies that form the basis of our standard of care.
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Esophageal Neoplasms
/
Carcinoma, Squamous Cell
/
Adenocarcinoma
Limits:
Humans
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2022
Document type:
Article
Institution/Affiliation country:
Complexo Hospitalario Universitario de Ourense/Spain
/
Doce de Octubre University Hospital/Spain
/
Hospital General Universitario de Elche/Spain
/
Hospital Universitari I Politècnic la Fe/Spain
/
Hospital Universitario Marqués de Valdecilla and Instituto de Investigación Marqués de Valdecilla (IDIVAL)/Spain
/
Hospital Universitario de Navarra (HUN)/Spain
/
Hospital Universitario la Paz/Spain
/
Hospital Virgen de la Salud/Spain
/
Institut Català dOncologia Hospital Duran i Reynals, CIBERONC/Spain
/
Regional and Virgen de la Victoria University Hospitals/Spain